Search

Search Constraints

You searched for: Author/Creator Roboz, Gail

Search Results

2. Colonization with Ceftriaxone-resistant Enterobacteriaceae and Risk of Bacteremia in Patients Receiving Induction Chemotherapy for Acute Leukemia. (4th October 2017)

3. Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. Issue 33 (20th November 2021)

4. 194 Antecedent Conformity of Diagnostic and Molecular Testing Patterns in Clinical Practice for Newly Diagnosed Acute Myeloid Leukemia With American Society of Hematology and College of American Pathologists Guidelines. (11th January 2018)

5. CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights. (October 2022)

6. Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. Issue 9 (September 2015)

7. Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. (14th July 2020)

8. Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R. Issue 10 (26th September 2018)

9. Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?. Issue 11 (November 2015)

10. Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. Issue 9 (September 2015)